투석기 시장 규모, 점유율, 동향 분석 보고서 : 플럭스별, 용도별, 막 재료별, 멸균 방법별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Dialyzer Market Summary

The global dialyzer market size was valued at USD 6.1 billion in 2025 and is projected to grow from USD 6.6 billion in 2026 to USD 12.1 billion by 2033, at a CAGR of 9.0% from 2026 to 2033. Asia Pacific dominated the market, accounting for the largest revenue share of 39.8% in 2025. The growth of the global dialyzer industry is primarily attributed to the increasing prevalence of chronic kidney disease (CKD) and end-stage kidney disease (ESKD), fueled by the rising incidence of diabetes, hypertension, obesity, and the growing aging population worldwide.

In addition, the increasing adoption of advanced dialysis technologies, including high-volume hemodiafiltration (HVHDF), is driving growth in the dialyzer market. Healthcare providers are implementing innovative dialysis therapies that improve toxin removal, enhance treatment efficiency, and support better patient outcomes. This trend is accelerating demand for technologically advanced dialyzers that are compatible with high-performance hemodialysis and hemodiafiltration systems. For instance, in July 2026, Fresenius Medical Care announced the BEACON-US research initiative to generate real-world clinical evidence on high-volume hemodiafiltration (HVHDF) among U.S. dialysis patients. The initiative supported the nationwide rollout of HVHDF by evaluating patient outcomes, treatment effectiveness, and clinical experiences across diverse patient populations.

"BEACON-US reflects our commitment to innovation that is grounded in evidence," said Helen Giza, CEO of Fresenius Medical Care. "High-volume hemodiafiltration has the potential to transform the standard of kidney care in the United States and is a key part of our FME Reignite strategy as we accelerate growth and innovation. We are excited by the benefits we are seeing through early insights from BEACON-US and the potential for this therapy to significantly improve patient outcomes."

Governments across the world are increasing investments in dialysis infrastructure, reimbursement programs, and public healthcare initiatives to improve access to renal replacement therapy for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). These initiatives are expanding dialysis capacity, particularly in underserved regions, thereby driving demand for dialyzers and other dialysis consumables. For instance, in August 2026, India's Pradhan Mantri National Dialysis Program (PMNDP) continued to strengthen dialysis services by expanding affordable treatment across district hospitals through public-private partnership (PPP) and in-house service delivery models. The program addresses the country's growing ESRD burden, with approximately 220,000 new ESRD patients requiring an additional 34 million dialysis sessions annually, supporting increased demand for dialyzers and dialysis infrastructure.

Global Dialyzer Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global dialyzer market report based on flux, usage, membrane material, sterilization method, end use, and region:

• Flux Outlook (Revenue, USD Billion, 2021 - 2033)
• High-Flux
• Low-Flux
• Medium Cut-Off (MCO)
• High Cut-Off (HCO)
• Usage Outlook (Revenue, USD Billion, 2021 - 2033)
• Disposable
• Reusable
• Membrane Material Outlook (Revenue, USD Billion, 2021 - 2033)
• Cellulose-Based
• Synthetic Membranes
• Polysulfone (PS)
• Polyethersulfone (PES)
• Polyarylethersulfone (PAES)
• Others
• Sterilization Method Outlook (Revenue, USD Billion, 2021 - 2033)
• Steam Sterilization
• Ethylene Oxide Sterilization
• Gamma/E-beam Sterilization
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• In-Center Dialysis
• Hospitals
• Standalone Dialysis Centers
• Home Healthcare
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Dialyzer Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising prevalence of chronic kidney disease (CKD) and end-stage kidney disease (ESKD)
    • 3.2.1.2. Increasing adoption of high-flux dialyzers and hemodiafiltration (HDF)
    • 3.2.1.3. Expanding government dialysis programs and reimbursement support
    • 3.2.1.4. Growing demand for home hemodialysis therapies
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost of dialysis treatment and infrastructure
    • 3.2.2.2. Limited access to dialysis care in low- and middle-income countries
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Expansion of dialysis services in emerging economies
    • 3.2.3.2. Growing adoption of home dialysis worldwide
    • 3.2.3.3. Integration of AI and digital technologies in dialysis care
    • 3.2.3.4. Increasing demand for personalized dialysis treatment
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Environmental burden from single-use dialyzers and dialysis waste
    • 3.2.4.2. Maintaining high toxin clearance while improving membrane biocompatibility
• 3.3. Dialyzer Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Dialyzer Market: Flux Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Dialyzer Market: Flux Movement Analysis, 2025 & 2033 (USD Billion)
• 4.3. Global Dialyzer Market Size & Trend Analysis, by Flux, 2021 to 2033 (USD Billion)
• 4.4. High-Flux
  • 4.4.1. High-flux market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.5. Low-Flux
  • 4.5.1. Low-flux market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.6. Medium Cut-Off (MCO)
  • 4.6.1. Medium Cut-Off (MCO) market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.7. High Cut-Off (MCO)
  • 4.7.1. High Cut-Off (MCO) market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Dialyzer Market: Usage Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Dialyzer Market: Usage Movement Analysis, 2025 & 2033 (USD Billion)
• 5.3. Global Dialyzer Market Size & Trend Analysis, by Usage, 2021 to 2033 (USD Billion)
• 5.4. Disposable
  • 5.4.1. Disposable market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 5.5. Reusable
  • 5.5.1. Reusable market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Dialyzer Market: Membrane Material Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Dialyzer Market: Membrane Material Movement Analysis, 2025 & 2033 (USD Billion)
• 6.3. Global Dialyzer Market Size & Trend Analysis, by Membrane Material 2021 to 2033 (USD Billion)
• 6.4. Cellulose-Based
  • 6.4.1. Cellulose-based market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.5. Synthetic Membranes
  • 6.5.1. Synthetic membranes market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.5.2. Polysulfone (PS)
    • 6.5.2.1. Polysulfone (PS) market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.5.3. Polyethersulfone (PES)
    • 6.5.3.1. Polyethersulfone (PES) market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.5.4. Polyarylethersulfone (PAES)
    • 6.5.4.1. Polyarylethersulfone (PAES) market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.5.5. Others
    • 6.5.5.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Dialyzer Market: Sterilization Method Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Dialyzer Market: Sterilization Method Movement Analysis, 2025 & 2033 (USD Billion)
• 7.3. Global Dialyzer Market Size & Trend Analysis, by Sterilization Method, 2021 to 2033 (USD Billion)
• 7.4. Steam Sterilization
  • 7.4.1. Steam sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.5. Ethylene Oxide Sterilization
  • 7.5.1. Ethylene oxide sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.6. Gamma/E-beam Sterilization
  • 7.6.1. Gamma/E-beam sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Dialyzer Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Dialyzer Market: End Use Movement Analysis, 2025 & 2033 (USD Billion)
• 8.3. Global Dialyzer Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
• 8.4. In-Center Dialysis
  • 8.4.1. In-center dialysis market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 8.4.2. Hospitals
    • 8.4.2.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 8.4.3. Standalone Dialysis Centers
    • 8.4.3.1. Standalone dialysis centers market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
• 8.5. Home Healthcare
  • 8.5.1. Home healthcare market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Dialyzer Market: Regional Estimates & Trend Analysis by Flux, Usage, Membrane Material, Sterilization Method, and End Use

• 9.1. Regional Dashboard
• 9.2. Market Size and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. North America dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Competitive scenario
    • 9.3.2.3. Regulatory framework
    • 9.3.2.4. Reimbursement scenario
    • 9.3.2.5. U.S. dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Competitive scenario
    • 9.3.3.3. Regulatory framework
    • 9.3.3.4. Reimbursement scenario
    • 9.3.3.5. Canada dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Competitive scenario
    • 9.3.4.3. Regulatory framework
    • 9.3.4.4. Reimbursement scenario
    • 9.3.4.5. Mexico dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.4. Europe
  • 9.4.1. Europe dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.2. UK
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. Reimbursement scenario
    • 9.4.2.5. UK dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.3. Germany
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Reimbursement scenario
    • 9.4.3.5. Germany dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.4. France
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Reimbursement scenario
    • 9.4.4.5. France dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.5. Italy
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory framework
    • 9.4.5.4. Reimbursement scenario
    • 9.4.5.5. Italy dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.6. Spain
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory framework
    • 9.4.6.4. Reimbursement scenario
    • 9.4.6.5. Spain dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Competitive scenario
    • 9.4.7.3. Regulatory framework
    • 9.4.7.4. Reimbursement scenario
    • 9.4.7.5. Sweden dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Competitive scenario
    • 9.4.8.3. Regulatory framework
    • 9.4.8.4. Reimbursement scenario
    • 9.4.8.5. Denmark dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.9. Norway
    • 9.4.9.1. Key country dynamics
    • 9.4.9.2. Competitive scenario
    • 9.4.9.3. Regulatory framework
    • 9.4.9.4. Reimbursement scenario
    • 9.4.9.5. Norway dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. China dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.3. Japan
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. Japan dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.4. India
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. India dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Reimbursement scenario
    • 9.5.5.5. South Korea dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.6. Australia
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Reimbursement scenario
    • 9.5.6.5. Australia dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.7. Thailand
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Competitive scenario
    • 9.5.7.3. Regulatory framework
    • 9.5.7.4. Reimbursement scenario
    • 9.5.7.5. Thailand dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.6. Latin America
  • 9.6.1. Latin America dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.6.2. Brazil
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. Brazil dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.6.3. Argentina
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Competitive scenario
    • 9.6.3.3. Regulatory framework
    • 9.6.3.4. Reimbursement scenario
    • 9.6.3.5. Argentina dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.7. Middle East and Africa
  • 9.7.1. Middle East and Africa dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.7.2. South Africa
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. South Africa dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. Saudi Arabia dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.7.4. UAE
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. UAE dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Competitive scenario
    • 9.7.5.3. Regulatory framework
    • 9.7.5.4. Reimbursement scenario
    • 9.7.5.5. Kuwait dialyzer market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis by Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Market Share Analysis, 2025
• 10.4. Company Heat Map Analysis
• 10.5. Strategy Mapping
  • 10.5.1. Expansion
  • 10.5.2. Mergers & Acquisition
  • 10.5.3. Partnerships & Collaborations
  • 10.5.4. New Technology Launches
  • 10.5.5. Research And Development
  • 10.5.6. Company Profiles
  • 10.5.7. Fresenius Medical Care
    • 10.5.7.1. Company overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Product Benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. Baxter International
    • 10.5.8.1. Company overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Product Benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. Nipro Corporation
    • 10.5.9.1. Company overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Product Benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. B. Braun SE
    • 10.5.10.1. Company overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Product Benchmarking
    • 10.5.10.4. Strategic initiatives
  • 10.5.11. Asahi Kasei Medical
    • 10.5.11.1. Company overview
    • 10.5.11.2. Financial performance
    • 10.5.11.3. Product Benchmarking
    • 10.5.11.4. Strategic initiatives
  • 10.5.12. Nikkiso Co., Ltd.
    • 10.5.12.1. Company overview
    • 10.5.12.2. Financial performance
    • 10.5.12.3. Product Benchmarking
    • 10.5.12.4. Strategic initiatives
  • 10.5.13. Toray Medical Co., Ltd.
    • 10.5.13.1. Company overview
    • 10.5.13.2. Financial performance
    • 10.5.13.3. Product Benchmarking
    • 10.5.13.4. Strategic initiatives
  • 10.5.14. Shandong Weigao Group
    • 10.5.14.1. Company overview
    • 10.5.14.2. Financial performance
    • 10.5.14.3. Product Benchmarking
    • 10.5.14.4. Strategic initiatives
  • 10.5.15. Allmed Medical GmbH
    • 10.5.15.1. Company overview
    • 10.5.15.2. Financial performance
    • 10.5.15.3. Product Benchmarking
    • 10.5.15.4. Strategic initiatives
  • 10.5.16. Medica S.p.A.
    • 10.5.16.1. Company overview
    • 10.5.16.2. Financial performance
    • 10.5.16.3. Product Benchmarking
    • 10.5.16.4. Strategic initiatives
  • 10.5.17. Dialife SA
    • 10.5.17.1. Company overview
    • 10.5.17.2. Financial performance
    • 10.5.17.3. Product Benchmarking
    • 10.5.17.4. Strategic initiatives
  • 10.5.18. JMS Co., Ltd.
    • 10.5.18.1. Company overview
    • 10.5.18.2. Financial performance
    • 10.5.18.3. Product Benchmarking
    • 10.5.18.4. Strategic initiatives
  • 10.5.19. Farmasol
    • 10.5.19.1. Company overview
    • 10.5.19.2. Financial performance
    • 10.5.19.3. Product Benchmarking
    • 10.5.19.4. Strategic initiatives
  • 10.5.20. Medtronic plc
    • 10.5.20.1. Company overview
    • 10.5.20.2. Financial performance
    • 10.5.20.3. Product Benchmarking
    • 10.5.20.4. Strategic initiatives